Presentation
Intravascular or Extravasated Blood More Evil in Subarachnoid Hemorrhage?
SessionContinuation of Care
DescriptionDevelopment and advancement in neurocritical care have resulted in increased survival of subarachnoid hemorrhage (SAH) patients, resulting in increased morbidity that has a socioeconomic impact at individual and societal levels. The young SAH survivors have long-term cognitive disability. How much of this is from the event itself, how much of this is from the lingering effects of the type of treatment received, and how much of it is related to the late effects of this event is currently unknown. The proposed talk would summarize the role of extravasated subarachnoid blood products in secondary brain injury and discuss how genetic predisposition (e.g., haptoglobin genotype) may predispose some-more compared to others and whether mere mechanical removal of this extravasated blood is enough in decreasing patient morbidity. Additionally, systemic procoagulant and proinflammatory responses will be briefly discussed to highlight the role of intravascular blood, the interplay between these two processes in exacerbating secondary brain injury, and how these can be modulated to decrease patient morbidity and improve cognitive outcomes.
Speaker
Event Type
Breakout Session
TimeWednesday, October 16th2:25pm - 2:45pm PDT
LocationHarbor Ballrooms D-I
Science of Neurocritical Care
Coma
Status Epilepticus
Stroke
Subarachnoid Hemorrhage
Traumatic Brain Injury
Intermediate
Advanced